HHS 计划资助 ibogaine 治疗 PTSD 的研究
STAT+: HHS plans funding for research into ibogaine for PTSD
HHS 计划资助 ibogaine 治疗 PTSD 的研究。Ibogaine 是一种 psychedelics,此前已有相关研究显示其对 PTSD 有潜在疗效。
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
I’m plunging into psychedelia again — journalistically speaking. If you have any interesting tips on the matter, email me!
Oura deal may complicate Lilly’s GLP-1 telehealth ties
Eli Lilly already sends patients looking for a GLP-1 prescription to Counsel Health through its pharmacy platform LillyDirect. Now, smart ring maker Oura is buying Counsel, which could give Lilly a financial interest in a telehealth company it promotes. Lilly has agreed to buy $50 million in Oura stock if certain conditions are met, though the drugmaker says those conditions haven’t been met yet, STAT’s Elaine Chen writes.
STAT+ Exclusive Story
Already have an account? Log in

This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
来源:STAT Pharma 医药频道 · statnews.com